RV01

DEVELOPMENT STEP phase-1
SPONSOR MATRIX Radiopharm Theranostics [RADX]
MECHANISM TARGET // UNMAPPED_TARGET

[THERAPEUTIC_PROFILE]

Target Indications

B7-H3 Positive Solid Tumors

Mechanism Abstract

A monoclonal antibody bearing Lu177 isotope

[CLINICAL_TRIALS_REGISTRY]

// NO_ACTIVE_REGISTRY_STUDIES_FOUND (RV01)